Document is current
Any future updates will be listed below
-
Authors
Wang, Mengmeng
Daghlas, Iyas
Cao, Liping
Zhang, Zhizhong
Gill, Dipender
Sha, Luolin
Liu, Dandan
-
Funding
Funding for this research was provided by:
Major Program of Science and Technology Project of Changzhou Health Commission (ZD202403)
- License Information
-
More Information
Article History
Received: 5 February 2024
Accepted: 11 July 2025
First Online: 22 July 2025
Declarations
:
: All included studies had obtained ethical approval and informed consent. No additional ethical approval was needed in this study.
: Not applicable.
: Unrelated to this work, Dipender Gill is the Chief Executive Officer of Sequoia Genetics, a private limited company that works with investors, pharma, biotech, and academia by performing research that leverages genetic data to help inform drug discovery and development. All other authors reports no disclosures relevant to the manuscript.
